메뉴 건너뛰기




Volumn 16, Issue 3 SPEC. ISS., 2005, Pages 539-551

Hormonal contraception: Noncontraceptive benefits and medical contraindications

Author keywords

[No Author keywords available]

Indexed keywords


EID: 25844459488     PISSN: 15473368     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.admecli.2005.05.003     Document Type: Review
Times cited : (6)

References (78)
  • 1
    • 0032965532 scopus 로고    scopus 로고
    • Oral contraceptive health benefits: Perception versus reality
    • A. Kaunitz Oral contraceptive health benefits: perception versus reality Contraception 59 1999 29S 33S
    • (1999) Contraception , vol.59
    • Kaunitz, A.1
  • 2
    • 0028910708 scopus 로고
    • Net effect of oral contraceptive use on the risk of cancer in women in the United States
    • J.J. Schlesselman Net effect of oral contraceptive use on the risk of cancer in women in the United States Obstet Gynecol 85 1995 793 801
    • (1995) Obstet Gynecol , vol.85 , pp. 793-801
    • Schlesselman, J.J.1
  • 3
    • 0032514413 scopus 로고    scopus 로고
    • Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group
    • S.A. Narod, H. Risch, and R. Moslehi Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group N Engl J Med 339 1998 424 428
    • (1998) N Engl J Med , vol.339 , pp. 424-428
    • Narod, S.A.1    Risch, H.2    Moslehi, R.3
  • 4
    • 0035061461 scopus 로고    scopus 로고
    • Oral contraceptives, other methods of contraception, and risk reduction for ovarian cancer
    • R.B. Ness, J.A. Grisso, and R. Vergona Oral contraceptives, other methods of contraception, and risk reduction for ovarian cancer Epidemiology 12 2001 307 312
    • (2001) Epidemiology , vol.12 , pp. 307-312
    • Ness, R.B.1    Grisso, J.A.2    Vergona, R.3
  • 5
    • 0026731343 scopus 로고
    • A quantitative assessment of oral contraceptive use and risk of ovarian cancer
    • S.E. Hankinson, G.A. Colditz, and D.J. Hunter A quantitative assessment of oral contraceptive use and risk of ovarian cancer Obstet Gynecol 80 1992 708 714
    • (1992) Obstet Gynecol , vol.80 , pp. 708-714
    • Hankinson, S.E.1    Colditz, G.A.2    Hunter, D.J.3
  • 6
    • 0025281245 scopus 로고
    • Pregnancy, breastfeeding, and oral contraceptives and the risk of epithelial ovarian cancer
    • M.L. Gwinn, N.C. Lee, and P.H. Rhodes Pregnancy, breastfeeding, and oral contraceptives and the risk of epithelial ovarian cancer J Clin Epidemiol 43 1990 559 568
    • (1990) J Clin Epidemiol , vol.43 , pp. 559-568
    • Gwinn, M.L.1    Lee, N.C.2    Rhodes, P.H.3
  • 7
    • 0030862208 scopus 로고    scopus 로고
    • Risk factors and hormone levels in patients with serous and endometrioid uterine carcinomas
    • M. Sherman, S. Sturgeon, and L.A. Brinton Risk factors and hormone levels in patients with serous and endometrioid uterine carcinomas Mod Pathol 10 1997 963 968
    • (1997) Mod Pathol , vol.10 , pp. 963-968
    • Sherman, M.1    Sturgeon, S.2    Brinton, L.A.3
  • 8
    • 0029029163 scopus 로고
    • Endometrial and ovarian cancer and oral contraceptives-findings in a large cohort study
    • M.P. Vessey, and R. Painter Endometrial and ovarian cancer and oral contraceptives-findings in a large cohort study Br J Cancer 71 1995 1340 1342
    • (1995) Br J Cancer , vol.71 , pp. 1340-1342
    • Vessey, M.P.1    Painter, R.2
  • 9
    • 0023857383 scopus 로고
    • The dose-effect relationship between unopposed oestrogens and endometrial mitotic rate: Its central role in explaining and predicting endometrial cancer risk
    • T.J. Key, and M.C. Pike The dose-effect relationship between unopposed oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk Br J Cancer 57 2 1988 205 212
    • (1988) Br J Cancer , vol.57 , Issue.2 , pp. 205-212
    • Key, T.J.1    Pike, M.C.2
  • 10
    • 0032464935 scopus 로고    scopus 로고
    • Oral contraceptives and colorectal tumors: A review of epidemiologic studies
    • S. Franceschi, and C. La Vecchia Oral contraceptives and colorectal tumors: a review of epidemiologic studies Contraception 58 1998 335 343
    • (1998) Contraception , vol.58 , pp. 335-343
    • Franceschi, S.1    La Vecchia, C.2
  • 11
    • 0035793815 scopus 로고    scopus 로고
    • Oral contraceptives and colorectal cancer risk: A meta-analysis
    • E. Fernandez, and C. La Vecchia Oral contraceptives and colorectal cancer risk: a meta-analysis Br J Cancer 84 5 2001 722 727
    • (2001) Br J Cancer , vol.84 , Issue.5 , pp. 722-727
    • Fernandez, E.1    La Vecchia, C.2
  • 12
    • 0031032674 scopus 로고    scopus 로고
    • A prospective study of reproductive factors, oral contraceptive use, and risk of colorectal cancer
    • M.E. Martinez, F. Grodstein, and E. Giovannucci A prospective study of reproductive factors, oral contraceptive use, and risk of colorectal cancer Cancer Epidemiol Biomarkers Prev 6 1997 1 5
    • (1997) Cancer Epidemiol Biomarkers Prev , vol.6 , pp. 1-5
    • Martinez, M.E.1    Grodstein, F.2    Giovannucci, E.3
  • 13
    • 0023198510 scopus 로고
    • Ovarian neoplasms, functional ovarian cysts, and oral contraceptives
    • M. Vessey, A. Metcalfe, and C. Wells Ovarian neoplasms, functional ovarian cysts, and oral contraceptives BMJ (Clin Res Ed) 294 6586 1987 1518 1520
    • (1987) BMJ (Clin Res Ed) , vol.294 , Issue.6586 , pp. 1518-1520
    • Vessey, M.1    Metcalfe, A.2    Wells, C.3
  • 14
    • 0026553956 scopus 로고
    • Oral contraceptive type and functional ovarian cysts
    • S. Lanes, B. Birmann, and A.M. Walker Oral contraceptive type and functional ovarian cysts Am J Obstet Gynecol 166 1992 956 961
    • (1992) Am J Obstet Gynecol , vol.166 , pp. 956-961
    • Lanes, S.1    Birmann, B.2    Walker, A.M.3
  • 15
    • 0028091146 scopus 로고
    • Ovulation and follicular development associated with three low-dose oral contraceptives: A randomized controlled trial
    • D.A. Grimes, A.J. Godwin, and A. Rubin Ovulation and follicular development associated with three low-dose oral contraceptives: a randomized controlled trial Obstet Gynecol 83 1994 29 34
    • (1994) Obstet Gynecol , vol.83 , pp. 29-34
    • Grimes, D.A.1    Godwin, A.J.2    Rubin, A.3
  • 16
    • 0031899417 scopus 로고    scopus 로고
    • Oral contraceptive use and benign gynecologic conditions: A review
    • F. Chiaffarino, F. Parazzini, and C. La Vecchia Oral contraceptive use and benign gynecologic conditions: a review Contraception 57 1998 11 18
    • (1998) Contraception , vol.57 , pp. 11-18
    • Chiaffarino, F.1    Parazzini, F.2    La Vecchia, C.3
  • 17
    • 0026787069 scopus 로고
    • A randomized, double-blind, placebo-controlled comparison of the impact of low-dose and triphasic oral contraceptives on follicular development
    • R.L. Young, M.C. Snabes, and M.L. Frank A randomized, double-blind, placebo-controlled comparison of the impact of low-dose and triphasic oral contraceptives on follicular development Am J Obstet Gynecol 167 1992 678 682
    • (1992) Am J Obstet Gynecol , vol.167 , pp. 678-682
    • Young, R.L.1    Snabes, M.C.2    Frank, M.L.3
  • 18
    • 0030693350 scopus 로고    scopus 로고
    • Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris
    • A.W. Lucky, T.A. Henderson, and W.H. Olson Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris J Am Acad Dermatol 37 5 1997 746 754
    • (1997) J Am Acad Dermatol , vol.37 , Issue.5 , pp. 746-754
    • Lucky, A.W.1    Henderson, T.A.2    Olson, W.H.3
  • 19
    • 0031127746 scopus 로고    scopus 로고
    • Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: A randomized, placebo-controlled trial
    • G.P. Redmond, W.H. Olson, and J.S. Lippman Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: a randomized, placebo-controlled trial Obstet Gynecol 89 4 1997 615 622
    • (1997) Obstet Gynecol , vol.89 , Issue.4 , pp. 615-622
    • Redmond, G.P.1    Olson, W.H.2    Lippman, J.S.3
  • 20
    • 0027570086 scopus 로고
    • Oral contraceptive use and risk of benign breast disease in a French case-control study of young women
    • I. Charreau, G. Plu-Bureau, and A. Bachelot Oral contraceptive use and risk of benign breast disease in a French case-control study of young women Eur J Cancer Prev 2 2 1993 147 154
    • (1993) Eur J Cancer Prev , vol.2 , Issue.2 , pp. 147-154
    • Charreau, I.1    Plu-Bureau, G.2    Bachelot, A.3
  • 21
    • 0032975454 scopus 로고    scopus 로고
    • A cohort study of oral contraceptive use and benign breast disease
    • T.E. Rohan, and A.B. Miller A cohort study of oral contraceptive use and benign breast disease Int J Cancer 82 2 1999 191 196
    • (1999) Int J Cancer , vol.82 , Issue.2 , pp. 191-196
    • Rohan, T.E.1    Miller, A.B.2
  • 22
    • 0024362567 scopus 로고
    • The health effects of oral contraceptives: Misperceptions, controversies, and continuing good news
    • H.B. Petersen, and N.C. Lee The health effects of oral contraceptives: misperceptions, controversies, and continuing good news Clin Obstet Gynecol 32 1989 339 355
    • (1989) Clin Obstet Gynecol , vol.32 , pp. 339-355
    • Petersen, H.B.1    Lee, N.C.2
  • 23
    • 0021823683 scopus 로고
    • Laparoscopic findings and contraceptive use in women with signs and symptoms suggestive of acute salpingitis
    • P. Wolner-Hanssen, L. Svensson, and P.A. Mardh Laparoscopic findings and contraceptive use in women with signs and symptoms suggestive of acute salpingitis Obstet Gynecol 66 1985 233 238
    • (1985) Obstet Gynecol , vol.66 , pp. 233-238
    • Wolner-Hanssen, P.1    Svensson, L.2    Mardh, P.A.3
  • 24
    • 0020454832 scopus 로고
    • Oral contraceptives and pelvic inflammatory disease
    • G.L. Rubin, H.W. Ory, and P.M. Layde Oral contraceptives and pelvic inflammatory disease Am J Obstet Gynecol 144 1982 630 635
    • (1982) Am J Obstet Gynecol , vol.144 , pp. 630-635
    • Rubin, G.L.1    Ory, H.W.2    Layde, P.M.3
  • 25
    • 0025141372 scopus 로고
    • Decreased risk of symptomatic chlamydial pelvic inflammatory disease associated with oral contraceptive use
    • P. Wolner-Hanssen, D.A. Eschenbach, and J. Paavonen Decreased risk of symptomatic chlamydial pelvic inflammatory disease associated with oral contraceptive use JAMA 263 1990 54 59
    • (1990) JAMA , vol.263 , pp. 54-59
    • Wolner-Hanssen, P.1    Eschenbach, D.A.2    Paavonen, J.3
  • 26
    • 0026025817 scopus 로고
    • Type of oral contraceptive in relation to acute, initial episodes of pelvic inflammatory disease
    • L.A. Panser, and W.R. Phipps Type of oral contraceptive in relation to acute, initial episodes of pelvic inflammatory disease Contraception 43 1991 91 99
    • (1991) Contraception , vol.43 , pp. 91-99
    • Panser, L.A.1    Phipps, W.R.2
  • 27
    • 0029587288 scopus 로고
    • Contraception and the risk of ectopic pregnancy: A meta-analysis
    • B.W. Mol, W.M. Ankum, and P.M. Bossuyt Contraception and the risk of ectopic pregnancy: a meta-analysis Contraception 52 1995 337 341
    • (1995) Contraception , vol.52 , pp. 337-341
    • Mol, B.W.1    Ankum, W.M.2    Bossuyt, P.M.3
  • 28
    • 0025644342 scopus 로고
    • The influence of different combined oral contraceptives on the prevalence and severity of dysmenorrhea
    • I. Milsom, G. Sundell, and B. Andersch The influence of different combined oral contraceptives on the prevalence and severity of dysmenorrhea Contraception 42 1990 497 506
    • (1990) Contraception , vol.42 , pp. 497-506
    • Milsom, I.1    Sundell, G.2    Andersch, B.3
  • 29
    • 0026806578 scopus 로고
    • The influence of a low-dose combined oral contraceptive on menstrual blood loss and iron status
    • G. Larsson, I. Milsom, and G. Lindstedt The influence of a low-dose combined oral contraceptive on menstrual blood loss and iron status Contraception 46 1992 327 334
    • (1992) Contraception , vol.46 , pp. 327-334
    • Larsson, G.1    Milsom, I.2    Lindstedt, G.3
  • 30
    • 0024446471 scopus 로고
    • The influence of a combined oral contraceptive on uterine activity and reactivity to agonists in primary dysmenorrhea
    • A. Hauksson, P. Ekström, and E. Juchnicka The influence of a combined oral contraceptive on uterine activity and reactivity to agonists in primary dysmenorrhea Acta Obstet Gynecol Scand 68 1989 31 34
    • (1989) Acta Obstet Gynecol Scand , vol.68 , pp. 31-34
    • Hauksson, A.1    Ekström, P.2    Juchnicka, E.3
  • 31
    • 0026022033 scopus 로고
    • Randomized trial of 2 hormonal and 2 prostaglandin-inhibition agents in women with a complaint of menorrhagia
    • I. Fraser, and G. McCarron Randomized trial of 2 hormonal and 2 prostaglandin-inhibition agents in women with a complaint of menorrhagia Aust NZ J Obstet Gynecol 31 1991 66 70
    • (1991) Aust NZ J Obstet Gynecol , vol.31 , pp. 66-70
    • Fraser, I.1    McCarron, G.2
  • 32
    • 84921430324 scopus 로고    scopus 로고
    • Oral contraceptive pills for heavy menstrual bleeding
    • V. Iyer Oral contraceptive pills for heavy menstrual bleeding Cochrane Database Syst Rev 3 1999 3
    • (1999) Cochrane Database Syst Rev , vol.3 , pp. 3
    • Iyer, V.1
  • 33
    • 84921430657 scopus 로고    scopus 로고
    • Modern combined oral contraceptives for pain associated with endometriosis
    • J. Moore, S. Kennedy, and A. Prentice Modern combined oral contraceptives for pain associated with endometriosis Cochrane Database Syst Rev 2 2000 CD001019
    • (2000) Cochrane Database Syst Rev , vol.2 , pp. 001019
    • Moore, J.1    Kennedy, S.2    Prentice, A.3
  • 34
    • 0033748855 scopus 로고    scopus 로고
    • Triphasic norgestimate-ethinyl estradiol for treating dysfunctional uterine bleeding
    • A. Davis, A. Godwin, and J. Lippman Triphasic norgestimate-ethinyl estradiol for treating dysfunctional uterine bleeding Obstet Gynecol 96 6 2000 913 920
    • (2000) Obstet Gynecol , vol.96 , Issue.6 , pp. 913-920
    • Davis, A.1    Godwin, A.2    Lippman, J.3
  • 35
    • 0037588442 scopus 로고    scopus 로고
    • Treatment of the adolescent patient with polycystic ovary syndrome
    • S. Pfeifer Treatment of the adolescent patient with polycystic ovary syndrome Obstet Gynecol Clin North Am 30 2 2003 337 352
    • (2003) Obstet Gynecol Clin North Am , vol.30 , Issue.2 , pp. 337-352
    • Pfeifer, S.1
  • 36
    • 0031716662 scopus 로고    scopus 로고
    • Iron status in 268 Danish women aged 18-30 years: Influence of menstruation, contraceptive method, and iron supplementation
    • N. Milman Iron status in 268 Danish women aged 18-30 years: influence of menstruation, contraceptive method, and iron supplementation Ann Hematol 77 1998 13 19
    • (1998) Ann Hematol , vol.77 , pp. 13-19
    • Milman, N.1
  • 37
    • 0031778658 scopus 로고    scopus 로고
    • Determining factors in the iron status of adult women in the SU.VI.MAX study. Supplementation en Vitamines et Mineraux Antioxydants
    • P. Galan, H.C. Yoon, and P. Preziosi Determining factors in the iron status of adult women in the SU.VI.MAX study. Supplementation en Vitamines et Mineraux Antioxydants Eur J Clin Nutr 52 6 1998 383 388
    • (1998) Eur J Clin Nutr , vol.52 , Issue.6 , pp. 383-388
    • Galan, P.1    Yoon, H.C.2    Preziosi, P.3
  • 38
    • 0033910734 scopus 로고    scopus 로고
    • Noncontraceptive benefits of oral contraceptive use: An evidence based approach
    • J. Williams Noncontraceptive benefits of oral contraceptive use: an evidence based approach Int J Fertil Womens Med 45 2000 241 247
    • (2000) Int J Fertil Womens Med , vol.45 , pp. 241-247
    • Williams, J.1
  • 39
    • 0022971053 scopus 로고
    • The effect of oral contraceptive use on vertebral bone mass in pre-and post-menopausal women
    • R. Lindsay, J. Tohme, and B. Kauders The effect of oral contraceptive use on vertebral bone mass in pre-and post-menopausal women Contraception 34 1986 333 340
    • (1986) Contraception , vol.34 , pp. 333-340
    • Lindsay, R.1    Tohme, J.2    Kauders, B.3
  • 40
    • 0034001434 scopus 로고    scopus 로고
    • Oral contraceptives and bone mineral density: A population-based study
    • J. Pasco, M.A. Kotowicz, and M.J. Henry Oral contraceptives and bone mineral density: a population-based study Am J Obstet Gynecol 182 2 2000 265 269
    • (2000) Am J Obstet Gynecol , vol.182 , Issue.2 , pp. 265-269
    • Pasco, J.1    Kotowicz, M.A.2    Henry, M.J.3
  • 41
    • 0033135999 scopus 로고    scopus 로고
    • Oral contraceptive use and risk of hip fracture: A case-control study
    • K. Michaelsson, J.A. Baron, and B.Y. Farahmand Oral contraceptive use and risk of hip fracture: a case-control study Lancet 353 9163 1999 1481 1484
    • (1999) Lancet , vol.353 , Issue.9163 , pp. 1481-1484
    • Michaelsson, K.1    Baron, J.A.2    Farahmand, B.Y.3
  • 42
    • 0022494390 scopus 로고
    • Risk factors for uterine fibroids: Reduced risk associated with oral contraceptives
    • R.K. Ross, M.C. Pike, and M.P. Vessey Risk factors for uterine fibroids: reduced risk associated with oral contraceptives BMJ 293 6543 1986 359 362
    • (1986) BMJ , vol.293 , Issue.6543 , pp. 359-362
    • Ross, R.K.1    Pike, M.C.2    Vessey, M.P.3
  • 43
    • 0032788520 scopus 로고    scopus 로고
    • Use of oral contraceptives and uterine fibroids: Results from a case-control study
    • F. Chiaffarino, F. Parazzini, and C. La Vecchia Use of oral contraceptives and uterine fibroids: results from a case-control study Br J Obstet Gynaecol 106 1999 857 860
    • (1999) Br J Obstet Gynaecol , vol.106 , pp. 857-860
    • Chiaffarino, F.1    Parazzini, F.2    La Vecchia, C.3
  • 44
    • 0030222013 scopus 로고    scopus 로고
    • Experiences of injectable contraceptive users in an urban setting
    • H. Sangi-Haghpeykar, A.N. Poindexter, and L. Bateman Experiences of injectable contraceptive users in an urban setting Obstet Gynecol 88 1996 227
    • (1996) Obstet Gynecol , vol.88 , pp. 227
    • Sangi-Haghpeykar, H.1    Poindexter, A.N.2    Bateman, L.3
  • 45
    • 0028964187 scopus 로고
    • Metabolic parameters, bleeding, and weight changes in US women using progestin-only contraceptives
    • R. Mainvaring Metabolic parameters, bleeding, and weight changes in US women using progestin-only contraceptives J Reprod Med 51 1995 149
    • (1995) J Reprod Med , vol.51 , pp. 149
    • Mainvaring, R.1
  • 46
    • 0028914373 scopus 로고
    • Medroxyprogesterone acetate (Depo-Provera) use in adolescents: Uterine bleeding and blood pressure patterns, patient satisfaction, and continuation rates
    • R.D. Smith, B.A. Cromer, and J.R. Hayes Medroxyprogesterone acetate (Depo-Provera) use in adolescents: uterine bleeding and blood pressure patterns, patient satisfaction, and continuation rates Adolesc Pediatr Gynecol 8 1995 24
    • (1995) Adolesc Pediatr Gynecol , vol.8 , pp. 24
    • Smith, R.D.1    Cromer, B.A.2    Hayes, J.R.3
  • 47
    • 0022544566 scopus 로고
    • A model clinic approach to the reproductive health concerns of the mentally handicapped
    • T.E. Elkins, S. Gafford, and D. Muram A model clinic approach to the reproductive health concerns of the mentally handicapped Obstet Gynecol 68 1986 185
    • (1986) Obstet Gynecol , vol.68 , pp. 185
    • Elkins, T.E.1    Gafford, S.2    Muram, D.3
  • 48
    • 0029952753 scopus 로고    scopus 로고
    • Depot medroxyprogesterone acetate contraception and the risk of breast and gynecologic cancer
    • A.M. Kaunitz Depot medroxyprogesterone acetate contraception and the risk of breast and gynecologic cancer J Reprod Med 41 Suppl 5 1996 419
    • (1996) J Reprod Med , vol.41 , Issue.5 SUPPL. , pp. 419
    • Kaunitz, A.M.1
  • 49
    • 0021802918 scopus 로고
    • Reduced risk of pelvic inflammatory disease with injectable contraceptives
    • R. Gray Reduced risk of pelvic inflammatory disease with injectable contraceptives Lancet 1 1985 1046
    • (1985) Lancet , vol.1 , pp. 1046
    • Gray, R.1
  • 50
    • 0029995769 scopus 로고    scopus 로고
    • Noncontraceptive benefits and therapeutic uses of depot medroxyprogesterone acetate
    • V. Cullins Noncontraceptive benefits and therapeutic uses of depot medroxyprogesterone acetate J Reprod Med 41 Suppl 5 1996 428
    • (1996) J Reprod Med , vol.41 , Issue.5 SUPPL. , pp. 428
    • Cullins, V.1
  • 51
    • 0025799993 scopus 로고
    • Depot-medroxyprogesterone acetate (DMPA) and risk of endometrial cancer
    • World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives
    • World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives Depot-medroxyprogesterone acetate (DMPA) and risk of endometrial cancer Int J Cancer 49 1991 191
    • (1991) Int J Cancer , vol.49 , pp. 191
  • 52
    • 0025721814 scopus 로고
    • In utero exposure to steroid contraceptives and survival during infancy
    • R.H. Gray, and T. Pardthaisong In utero exposure to steroid contraceptives and survival during infancy Am J Epidemiol 134 1991 804 811
    • (1991) Am J Epidemiol , vol.134 , pp. 804-811
    • Gray, R.H.1    Pardthaisong, T.2
  • 53
    • 0022632986 scopus 로고
    • Use of oral contraceptives by women with epilepsy
    • R.H. Mattson, J.A. Cramer, and P.D. Darney Use of oral contraceptives by women with epilepsy JAMA 256 2 1986 238 240
    • (1986) JAMA , vol.256 , Issue.2 , pp. 238-240
    • Mattson, R.H.1    Cramer, J.A.2    Darney, P.D.3
  • 54
    • 0027240969 scopus 로고
    • Contraceptive methods for women with neurologic disorders
    • R.H. Mattson, and R.W. Rebar Contraceptive methods for women with neurologic disorders Am J Obstet Gynecol 168 1993 2027 2032
    • (1993) Am J Obstet Gynecol , vol.168 , pp. 2027-2032
    • Mattson, R.H.1    Rebar, R.W.2
  • 56
    • 0036085736 scopus 로고    scopus 로고
    • Impact of early postpartum administration of progestin-only hormonal contraceptives compared with nonhormonal contraceptives on short-term breast-feeding patterns
    • L. Halderman Impact of early postpartum administration of progestin-only hormonal contraceptives compared with nonhormonal contraceptives on short-term breast-feeding patterns Am J Obstet Gynecol 186 6 2002 1250 1256
    • (2002) Am J Obstet Gynecol , vol.186 , Issue.6 , pp. 1250-1256
    • Halderman, L.1
  • 57
    • 18344407400 scopus 로고    scopus 로고
    • Combined hormonal versus nonhormonal versus progestin-only contraception in lactation
    • S. Truitt Combined hormonal versus nonhormonal versus progestin-only contraception in lactation Cochrane Database Syst Rev 2 2003 CD003988
    • (2003) Cochrane Database Syst Rev , vol.2 , pp. 003988
    • Truitt, S.1
  • 58
    • 0031725447 scopus 로고    scopus 로고
    • Hemostatic effects of oral contraceptives in women who developed deep-vein thrombosis while using oral contraceptives
    • K.W. Bloemenkamp, F.R. Rosendaal, and F.M. Helmerhorst Hemostatic effects of oral contraceptives in women who developed deep-vein thrombosis while using oral contraceptives Thromb Haemost 80 1998 382
    • (1998) Thromb Haemost , vol.80 , pp. 382
    • Bloemenkamp, K.W.1    Rosendaal, F.R.2    Helmerhorst, F.M.3
  • 59
    • 0030802060 scopus 로고    scopus 로고
    • A re-evaluation of the risk for venous thromboembolism with the use of oral contraceptives and hormone replacement therapy
    • J.D. Douketis, J.S. Ginsberg, and A. Holbrook A re-evaluation of the risk for venous thromboembolism with the use of oral contraceptives and hormone replacement therapy Arch Intern Med 157 14 1997 1522 1530
    • (1997) Arch Intern Med , vol.157 , Issue.14 , pp. 1522-1530
    • Douketis, J.D.1    Ginsberg, J.S.2    Holbrook, A.3
  • 60
    • 0036203526 scopus 로고    scopus 로고
    • Oral contraceptives and venous thromboembolism: A five-year national case-control study
    • O. Lidegaard, B. Edstrom, and S. Kreiner Oral contraceptives and venous thromboembolism: a five-year national case-control study Contraception 65 3 2002 187 196
    • (2002) Contraception , vol.65 , Issue.3 , pp. 187-196
    • Lidegaard, O.1    Edstrom, B.2    Kreiner, S.3
  • 61
    • 25844493258 scopus 로고
    • Effects of newer oral contraceptives on the inhibition of coagulation and fibrinolysis in relation to dosage and type of steroid
    • J. Jespersen, K.R. Peterson, and S.O. Skouby Effects of newer oral contraceptives on the inhibition of coagulation and fibrinolysis in relation to dosage and type of steroid Am J Obstet Gynecol 396 1990 163
    • (1990) Am J Obstet Gynecol , vol.396 , pp. 163
    • Jespersen, J.1    Peterson, K.R.2    Skouby, S.O.3
  • 62
    • 0026460281 scopus 로고
    • Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: A controlled comparative 12-month clinical trial
    • M. Notelovitz, C.S. Kitchens, and F.Y. Khan Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial Am J Obstet Gynecol 167 1992 1255
    • (1992) Am J Obstet Gynecol , vol.167 , pp. 1255
    • Notelovitz, M.1    Kitchens, C.S.2    Khan, F.Y.3
  • 63
    • 0028029477 scopus 로고
    • Increased risk of venous thrombosis in oral -contraceptive users who are carriers of factor V Leiden mutation
    • J.P. Vandenbroucke, T. Koster, and E. Briet Increased risk of venous thrombosis in oral -contraceptive users who are carriers of factor V Leiden mutation Lancet 344 1994 1453
    • (1994) Lancet , vol.344 , pp. 1453
    • Vandenbroucke, J.P.1    Koster, T.2    Briet, E.3
  • 64
    • 0032976317 scopus 로고    scopus 로고
    • Interaction between the G20210A mutation of the prothrombin gene and oral contraceptive use in deep vein thrombosis
    • I. Martinelli, E. Taioli, and P. Bucciarelli Interaction between the G20210A mutation of the prothrombin gene and oral contraceptive use in deep vein thrombosis Arterioscler Thromb Vasc Biol 19 1999 700
    • (1999) Arterioscler Thromb Vasc Biol , vol.19 , pp. 700
    • Martinelli, I.1    Taioli, E.2    Bucciarelli, P.3
  • 65
    • 0025181231 scopus 로고
    • Past use of oral contraceptives and cardiovascular disease: A meta-analysis in the context of the nurses' health study
    • M.J. Stampfer, W.C. Willett, and G.A. Colditz Past use of oral contraceptives and cardiovascular disease: a meta-analysis in the context of the nurses' health study Am J Obstet Gynecol 163 1990 285
    • (1990) Am J Obstet Gynecol , vol.163 , pp. 285
    • Stampfer, M.J.1    Willett, W.C.2    Colditz, G.A.3
  • 66
    • 0027199437 scopus 로고
    • Hemostatic and metabolic effects of lowering the ethinyl-estradiol dose from 30 mcg to 20 mcg in oral contraceptives containing desogestrel
    • A. Basdevant, J. Conard, and C. Pelissier Hemostatic and metabolic effects of lowering the ethinyl-estradiol dose from 30 mcg to 20 mcg in oral contraceptives containing desogestrel Contraception 48 1993 193 203
    • (1993) Contraception , vol.48 , pp. 193-203
    • Basdevant, A.1    Conard, J.2    Pelissier, C.3
  • 67
    • 19244367470 scopus 로고    scopus 로고
    • Acute myocardial infarction and combined oral contraceptives: Results of an international multi-centre case-control study
    • World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception
    • World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception Acute myocardial infarction and combined oral contraceptives: results of an international multi-centre case-control study Lancet 349 1997 1202 1209
    • (1997) Lancet , vol.349 , pp. 1202-1209
  • 68
    • 0033542402 scopus 로고    scopus 로고
    • The protective effects of estrogen on the cardiovascular system
    • M.E. Mendelsohn, and R.H. Karas The protective effects of estrogen on the cardiovascular system N Engl J Med 340 1999 1801 1811
    • (1999) N Engl J Med , vol.340 , pp. 1801-1811
    • Mendelsohn, M.E.1    Karas, R.H.2
  • 69
    • 0036202624 scopus 로고    scopus 로고
    • Contraceptives and cerebral thrombosis: A five-year national case-control study
    • O. Lidegaard Contraceptives and cerebral thrombosis: a five-year national case-control study Contraception 65 3 2002 197 205
    • (2002) Contraception , vol.65 , Issue.3 , pp. 197-205
    • Lidegaard, O.1
  • 70
    • 0029017772 scopus 로고
    • Relationship of headache to the phase of the menstrual cycle among young women: A daily diary study
    • C.B. Johannes, M.S. Linet, and W.F. Stewart Relationship of headache to the phase of the menstrual cycle among young women: a daily diary study Neurology 45 1995 1076 1082
    • (1995) Neurology , vol.45 , pp. 1076-1082
    • Johannes, C.B.1    Linet, M.S.2    Stewart, W.F.3
  • 71
    • 2442494842 scopus 로고    scopus 로고
    • Oestrogen and attacks of migraine with and without aura
    • E. MacGregor Oestrogen and attacks of migraine with and without aura Lancet Neurol 3 6 2004 354 361
    • (2004) Lancet Neurol , vol.3 , Issue.6 , pp. 354-361
    • MacGregor, E.1
  • 72
    • 0028959691 scopus 로고
    • Case-control study of migraine and risk of ischaemic stroke in young women
    • C. Tzourio, A. Tchindrazanarivelo, and S. Iglesias Case-control study of migraine and risk of ischaemic stroke in young women BMJ 310 1995 830 833
    • (1995) BMJ , vol.310 , pp. 830-833
    • Tzourio, C.1    Tchindrazanarivelo, A.2    Iglesias, S.3
  • 73
    • 0029906276 scopus 로고    scopus 로고
    • History of migraine and risk of cerebral ischaemia in young adults
    • A. Carolei, C. Marini, and G. De Matteis History of migraine and risk of cerebral ischaemia in young adults Lancet 347 1996 1503 1506
    • (1996) Lancet , vol.347 , pp. 1503-1506
    • Carolei, A.1    Marini, C.2    De Matteis, G.3
  • 74
    • 0033514057 scopus 로고    scopus 로고
    • Migraine and stroke in young women: Case-control study
    • C.L. Chang, M. Donaghy, and N. Poulter Migraine and stroke in young women: case-control study BMJ 318 1999 13 18
    • (1999) BMJ , vol.318 , pp. 13-18
    • Chang, C.L.1    Donaghy, M.2    Poulter, N.3
  • 76
    • 0033011026 scopus 로고    scopus 로고
    • Effects of progestins on cardiovascular diseases: The haemostatic system
    • U. Winkler Effects of progestins on cardiovascular diseases: the haemostatic system Hum Reprod Update 5 1999 200
    • (1999) Hum Reprod Update , vol.5 , pp. 200
    • Winkler, U.1
  • 77
    • 26444620400 scopus 로고
    • American College of Obstetricians and Gynecologists ACOG Washington (DC)
    • American College of Obstetricians and Gynecologists Hormonal contraception. ACOG Technical Bulletin 1994 ACOG Washington (DC) 198
    • (1994) Hormonal Contraception. ACOG Technical Bulletin , pp. 198
  • 78
    • 0031596001 scopus 로고    scopus 로고
    • The use of oral contraceptives by adolescents for contraception, menstrual cycle problems or acne
    • M. van Hooff The use of oral contraceptives by adolescents for contraception, menstrual cycle problems or acne Acta Obstet Gynecol Scand 77 1998 898 904
    • (1998) Acta Obstet Gynecol Scand , vol.77 , pp. 898-904
    • Van Hooff, M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.